VEGFA and neoplasm: In the same line of evidence, Shrimali et al. evaluated the synergism of anti-angiogenic agents with adoptive cell transfer therapy in a murine melanoma model, finding increased infiltration of the adoptively transferred cells into the tumor in combination with anti-VEGF therapy, and to a lesser extent when combined with DC101 antibody (99).